Affordable Access

Publisher Website

Dual-targeted polyplexes: One step towards a synthetic virus for cancer gene therapy

Authors
Journal
Journal of Controlled Release
0168-3659
Publisher
Elsevier
Publication Date
Volume
152
Issue
1
Identifiers
DOI: 10.1016/j.jconrel.2011.02.028
Keywords
  • Gene Transfer
  • Integrin
  • Plasmid Dna
  • Polyplex
  • Targeting
  • Transferrin
Disciplines
  • Engineering
  • Medicine

Abstract

Abstract Incorporating ligands into nano-scale carriers for specific delivery of therapeutic nucleic acids to tumor sites is a promising approach in anti-cancer strategies. Current artificial vector systems however still suffer from efficient and specific delivery, compared to their natural counterparts and addressed receptor types rarely are exclusively expressed on target cells. In this study synthetic dual receptor targeted polyplexes were developed, mimicking biphasic cell entry characteristics of natural viruses to increase efficiency and specificity by a dual-receptor internalization mechanism. For engineering the synthetic dual targeted vector system, the transferrin targeting peptide B6 was evaluated for the first time in the context of PEGylated PEI based polyplexes. As a second ligand, arginine–glycine–aspartic acid (RGD) containing peptide was incorporated for simultaneous integrin targeting. Cellular association, cellular uptake, transfection efficiency and accordant competition experiments displayed specificity of both ligands for each targeted receptor in two prostate cancer cell lines. A clear synergy of dual targeting over the combination of single-targeted polyplexes was found, suggesting that the dual targeting strategy is one step towards safe vectors for therapeutic approaches.

There are no comments yet on this publication. Be the first to share your thoughts.